Spontaneous carbonate formation in an amorphous, amine-rich, polymeric drug substance: sevelamer HCl product quality.

Spectral differences among multiple manufacturers/lots of sevelamer HCl were observed by Fourier transform infrared spectroscopy, and further characterization was performed to identify the cause for these differences. The drug substance is a polymer that possesses a large molecular weight, is amorphous, and is practically insoluble in both water and organic solvents. Thus, solid-state characterization methods (spectroscopic and thermal) were required to identify and characterize differences among the samples to assess possible differences in product quality. ¹³C cross-polarization-magic-angle-spinning nuclear magnetic resonance spectroscopy of sevelamer HCl substances demonstrated the presence of a carbonyl-containing species, which was attributed to a carbonate impurity among samples. Stability studies demonstrated that this carbonate impurity formed spontaneously upon exposure of the drug substance to atmospheric water vapor and carbon dioxide, even under ambient conditions. Mechanistically, this behavior likely arises from the large number of primary and secondary amine groups, the hygroscopicity of the HCl salt, and a high degree of molecular mobility due to the amorphous nature of the drug substance.

[1]  E. Munson,et al.  Analysis of composition, molecular weight, and water content variations in sodium alginate using solid-state NMR spectroscopy. , 2011, Journal of pharmaceutical sciences.

[2]  J. Rocha,et al.  Adsorption and Activation of CO2 by Amine-Modified Nanoporous Materials Studied by Solid-State NMR and 13CO2 Adsorption , 2011 .

[3]  F. Vogt,et al.  Detection of low-level PTFE contamination: An application of solid-state NMR to structure elucidation in the pharmaceutical industry. , 2011, Journal of pharmaceutical and biomedical analysis.

[4]  Rafael do Espírito Santo,et al.  A comparative solid state 13C NMR and thermal study of CO2 capture by amidines PMDBD and DBN , 2011 .

[5]  S. Fan,et al.  A randomized, crossover design study of sevelamer carbonate powder and sevelamer hydrochloride tablets in chronic kidney disease patients on haemodialysis , 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[6]  Brian M. Shepler,et al.  Comparison of Sevelamer Hydrochloride and Sevelamer Carbonate: Risk of Metabolic Acidosis and Clinical Implications , 2009, Pharmacotherapy.

[7]  Marco Geppi,et al.  Solid‐State NMR Studies of Pharmaceutical Systems , 2008 .

[8]  S. Chasan-Taber,et al.  A randomized, double-blind, crossover design study of sevelamer hydrochloride and sevelamer carbonate in patients on hemodialysis. , 2007, Clinical nephrology.

[9]  R. T. Berendt,et al.  Solid-state NMR spectroscopy in pharmaceutical research and analysis , 2006 .

[10]  G. Zografi,et al.  Molecular Mobility in Mixtures of Absorbed Water and Solid Poly(vinylpyrrolidone) , 1993, Pharmaceutical Research.

[11]  Susan Budavari,et al.  The Merck index : an encyclopedia of chemicals, drugs, and biologicals , 1983 .